|
1
|
Jemal A, Ward E and Thun M: Declining
death rates reflect progress against cancer. PLoS One.
5:e9584–e9591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sciarra A, Salciccia S and Panebianco V:
Proton spectroscopic and dynamic contrast-enhanced magnetic
resonance: a modern approach in prostate cancer imaging. Eur Urol.
54:485–488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crawford ED: Epidemiology of prostate
cancer. Urology. 62:3–12. 2003. View Article : Google Scholar
|
|
4
|
Zhang L, Yang BX, Zhang HT, Wang JG, Wang
HL and Zhao XJ: Prostate cancer: an emerging threat to the health
of aging men in Asia. Asian J Androl. 13:574–578. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xia SJ, Cui D and Jiang Q: An overview of
prostate diseases and their characteristics specific to Asian men.
Asian J Androl. 14:458–464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Neto CC, Amoroso JW and Liberty AM:
Anticancer activities of cranberry phytochemicals: an update. Mol
Nutr Food Res. 52:S18–S27. 2008.PubMed/NCBI
|
|
7
|
Kaur M, Pop M, Shi D, Brignone C and
Grossman SR: hHR23B is required for genotoxic-specific activation
of p53 and apoptosis. Oncogene. 26:1231–1237. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Igney FH and Krammer PH: Immune escape of
tumors: apoptosis resistance and tumor counterattack. J Leukoc
Biol. 71:907–920. 2002.PubMed/NCBI
|
|
9
|
Hu W and Kavanagh JJ: Anticancer therapy
targeting the apoptotic pathway. Lancet Oncol. 4:721–729. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pathak N and Khandelwal S: Role of
oxidative stress and apoptosis in cadmium induced thymic atrophy
and splenomegaly in mice. Toxicol Lett. 169:95–108. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chatterjee S, Kundu S, Bhattacharyya A,
Hartinger CG and Dyson PJ: The ruthenium(II)-arene compound RAPTA-C
induces apoptosis in EAC cells through mitochondrial and p53-JNK
pathways. J Biol Inorg Chem. 13:1149–1155. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huppertz B, Kadyrov M and Kingdom JC:
Apoptosis and its role in the trophoblast. Am J Obstet Gynecol.
195:29–39. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou H, Liu X, Liu L, Yang Z, Zhang S,
Tang M, Tang Y, Dong Q and Hu R: Oxidative stress and apoptosis of
human brain microvascular endothelial cells induced by free fatty
acids. J Int Med Res. 37:1897–1903. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang MF, Liao YF, Hung YC, Lin CL, Hour
TC, Lue KH, Hung HC and Liu GY: Hydroxydibenzoylmethane induces
apoptosis through repressing ornithine decarboxylase in human
promyelocytic leukemia HL-60 cells. Exp Mol Med. 43:189–196. 2011.
View Article : Google Scholar
|
|
15
|
Cunningham KG, Manson W, Spring FS and
Hutchinson SA: Cordycepin, a metabolic product isolated from
cultures of Cordyceps militaris. Nature. 166:9491950.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paterson RR: Cordyceps: a traditional
Chinese medicine and another fungal therapeutic biofactory?
Phytochemistry. 69:1469–1495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Horowitz B, Goldfinger BA and Marmur J:
Effect of cordycepin triphosphate on the nuclear DNA-dependent RNA
polymerases and poly(A) polymerase from the yeast, Saccharomyces
cerevisiae. Arch Biochem Biophys. 172:143–148. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Müller WE, Seibert G, Beyer R, Breter HJ,
Maidhof A and Zahn RK: Effect of cordycepin on nucleic acid
metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme
systems. Cancer Res. 37:3824–3833. 1977.
|
|
19
|
Foss FM: Combination therapy with purine
nucleoside analogs. Oncology. 14:31–35. 2000.PubMed/NCBI
|
|
20
|
Nakamura K, Yoshikawa N, Yamaguchi Y,
Kagota S, Shinozuka K and Kunitomo M: Antitumor effect of
cordycepin (3′-deoxyadenosine) on mouse melanoma and lung carcinoma
cells involves adenosine A3 receptor stimulation. Anticancer Res.
26:43–47. 2006.
|
|
21
|
Sugar AM and McCaffrey RP: Antifungal
activity of 3′-deoxyadenosine (cordycepin). Antimicrob Agents
Chemother. 42:1424–1427. 1998.
|
|
22
|
Ahn YJ, Park SJ, Lee SG, Shin SC and Choi
DH: Cordycepin: selective growth inhibitor derived from liquid
culture of Cordyceps militaris against Clostridium
spp. J Agric Food Chem. 48:2744–2748. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim HG, Shrestha B, Lim SY, Yoon DH, Chang
WC, Shin DJ, Han SK, Park SM, Park JH, Park HI, Sung JM, Jang Y,
Chung N, Hwang KC and Kim TW: Cordycepin inhibits
lipopolysaccharide-induced inflammation by the suppression of
NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage
cells. Eur J Pharmacol. 545:192–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jeong JW, Jin CY, Kim GY, Lee JD, Park C,
Kim GD, Kim WJ, Jung WK, Seo SK, Choi IW and Choi YH:
Anti-inflammatory effects of cordycepin via suppression of
inflammatory mediators in BV2 microglial cells. Int
Immunopharmacol. 10:1580–1586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou X, Gong Z, Su Y, Lin J and Tang K:
Cordyceps fungi: natural products, pharmacological functions
and developmental products. J Pharm Pharmacol. 61:279–291. 2009.
View Article : Google Scholar
|
|
26
|
Lee K, Lee MH, Kang YW, Rhee KJ, Kim TU
and Kim YS: Parkin induces apoptotic cell death in TNF-α-treated
cervical cancer cells. BMB Rep. 45:526–531. 2012.PubMed/NCBI
|
|
27
|
Kim IH, Kim SW, Kim SH, Lee SO, Lee ST,
Kim DG, Lee MJ and Park WH: Parthenolide-induced apoptosis of
hepatic stellate cells and anti-fibrotic effects in an in
vivo rat model. Exp Mol Med. 44:448–456. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Chen S, Ma G, Ye M and Lu G:
Involvement of proinflammatory factors, apoptosis, caspase-3
activation and Ca2+ disturbance in microglia
activation-mediated dopaminergic cell degeneration. Mech Ageing
Dev. 126:1241–1254. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang HY and Yang X: Proteases for cell
suicide: functions and regulation of caspases. Microbiol Mol Biol
Rev. 64:821–846. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163.
2005.PubMed/NCBI
|
|
31
|
Deveraux QL, Roy N, Stennicke HR, Van
Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS and Reed
JC: IAPs block apoptotic events induced by caspase-8 and cytochrome
c by direct inhibition of distinct caspases. EMBO J. 17:2215–2223.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Borner C: The Bcl-2 protein family:
sensors and checkpoints for life-or-death decisions. Mol Immunol.
39:615–647. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Griffiths GJ, Dubrez L, Morgan CP, Jones
NA, Whitehouse J, Corfe BM, Dive C and Hickman JA: Cell
damage-induced conformational changes of the pro-apoptotic protein
Bak in vivo precede the onset of apoptosis. J Cell Biol.
144:903–914. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wolter KG, Hsu YT, Smith CL, Nechushtan A,
Xi XG and Youle RJ: Movement of Bax from the cytosol to
mitochondria during apoptosis. J Cell Biol. 139:1281–1292. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bruce-Keller AJ, Begley JG, Fu W,
Butterfield DA, Bredesen DE, Hutchins JB, Hensley K and Mattson MP:
Bcl-2 protects isolated plasma and mitochondrial membranes against
lipid peroxidation induced by hydrogen peroxide and amyloid
beta-peptide. J Neurochem. 70:31–39. 1998. View Article : Google Scholar
|
|
36
|
Fiers W, Beyaert R, Declercq W and
Vandenabeele P: More than one way to die: apoptosis, necrosis and
reactive oxygen damage. Oncogene. 18:7719–7730. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fleury C, Mignotte B and Vayssière JL:
Mitochondrial reactive oxygen species in cell death signaling.
Biochimie. 84:131–141. 2002. View Article : Google Scholar : PubMed/NCBI
|
